Spectral AI, Inc. (MDAI): Nasdaq/NYSE listing notice — Nasdaq grants Rosecliff Acquisition Corp I 180-day extension to July 21, 2023 on minimum public shares rule

Spectral AI, Inc.

Nasdaq granted Rosecliff Acquisition Corp I a 180-day extension to July 21, 2023, to meet Rule 5550(a)(4) minimum 500,000 publicly held shares.
Extension is conditioned on the company's Business Combination Agreement with Spectral MD Holdings, Ltd.
By July 21, company must file with SEC and Nasdaq a document with current shares outstanding and beneficial ownership table.
If compliance not regained by July 21, Nasdaq will delist securities; company may appeal before a Listing Qualifications Panel.

item 3.01

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.9

Spectral AI, Inc. received a nasdaq extension granted notice regarding shareholders (rules 5550(a)(4)).

Exchange: nasdaq
Notice: extension granted
Deficiency: shareholders
Rules: 5550(a)(4)

Exact text from the filing

May 8, 2023, Rosecliff Acquisition Corp I (the “Company”) received a letter from The Nasdaq Stock Market (“Nasdaq”) advising that the Company had been granted a previously requested 180-day extension to July 21, 2023, to regain compliance with Rule 5550(a)(4), which requires the Company to hold a minimum of 500,000 publicly held shares. The Listing Qualifications Department of Nasdaq based its determination of an extension on the Company entering into the Business Combination Agreement with Spectral MD Holdings, Ltd. On or before July 21, 2023, the Company must file with the U.S. Securities an

View on SEC.gov

8 listing & compliance notices filed in the last 30 days. Browse all listing & compliance notices →

Spectral AI, Inc. filing history →

Source: SEC EDGAR

accession 0001213900-23-039005

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.